BIOGRAPHIC NOTE OF THE MEDICAL CHATZIFOTIADIS DANIEL
1. Director of the Limassol Nuclear Medicine Laboratory (from 11/2020 until today)
2. Director of the Laboratory of Nuclear Medicine 251 ENA
(from 04/2006 to 5/2019)
3. Scientific Officer of the ENHC Nuclear Medicine Laboratory (Henry Dunan from 2016-2018)
4. Scientific Officer of the Laboratory of Nuclear Medicine Private
Polymedium "THE SAINT ANARGYROI" (from 1999-2014)
Master in Science , MSc , NATIONAL KAPODISTRIAKOS
UNIVERSITY OF ATHENS , with the object of:
"NEOPLASTIC DISEASE TO HUMAN: DISCOGNISATION, CONCENTRATION
THERAPIA AND RESEARCH" from 2014-2016
Foreign education: 25-10-2004 to 25-10-2005 on
USA(JOHNS HOPKINS HOSPITAL-DEPARTMENT OF RADIOLOGYDIVISION OF NUCLEAR MEDICINE)
Specialization in PET/CT
MEDICAL REQUIREMENT LICENCE: 2271/16-01-1992/
ATHENS LEGAL/HEALTH MANAGEMENT
MEDICAL SPECIAL TITLE:3699/23-03-1999/ LEGAL
ATHENS /HEALTH MANAGEMENT
CERTIFICATE OF RECOGNITION OF TITLE SPECIFICATION IN
CYPRIAN REPUBLIC (Register No : 5666-09/07/2015)
ENGLISH IN THE CYPRUS MEDICAL MATERIAL
From 10-01-1992 to 24-12-1992 I was placed in 251 UNA for
practical rolling training (rotation in all Clinics)
From 24 -12 to 1992 I was transferred as a Doctor to the Health Service of the
111 Battle Wing, for two years (until 16-12-1994) and I was responsible for
health coverage on a primary scale.
From 19-12-1994 to 17-01-1999 I specialized in Nuclear Medicine in 251
YNA (one year-Internal Pathology) and Alexandra Hospital( three years Nuclear Medicine)
From 23-03-1999 to 12-09-1999 Curator of nuclear medicine laboratory 251 General Aviation Hospital (ENA)
On 13 - 9 - 1999 I was transferred as a doctor to the Health Service of 112
Battle Wing, and on 5-11-2000 I took over as Head of the Battle Wing.
I returned to 251 ENA on 22-11-01
From 22-11-2001 to 17-10-2004 Curator of the Laboratory of Nuclear Medicine
251 ENA
Foreign education: 25-10-2004 to 25-10-2005 in the USA (JOHNS
HOPKINS HOSPITAL-DEPARTMENT OF RADIOLOGY-DIVISION OF
NUCLEAR MEDICINE)
Specialization in :P ET/CT
From 07-11-2005 to 04-04-2006 Curator of nuclear medicine laboratory 251 ENA
From 04-04-2006 to 04-05-2019 Director of nuclear medicine laboratory 251 ENA
Scientific work
1. T. Athanasoulis, CA. Zerva. Interpretation of reverse
redistribution of Tc – 99m tetrofosmin in patients with acute myocardial infarction. (Letter to the editor)
Eur. J. Nucl. Med. Mol Imaging. 2003; 30(5):798 – 9(impact factor 4,991)
2. Assessment of Interobserver Reproducibility in Quantitative 18FFDG PET and CT Measurements of Tumor Response to Therapy
Heather A. Jacene, Sophie Leboulleux, Shingo Baba, Daniel Chatzifotiadis, Behnaz Goudarzi, Oleg Teytelbaum, Karen M. Horton,
Ihab Kamel, Katarzyna J. Macura, Hua-Ling Tsai, Jeanne Kowalski and Richard Wahl
JNM 2009 50: 11A-12A, p. 1760-1769(impact factor 7,022)
3. Importance of the same or different readers pre- and post-therapy for anatomic vs. metabolic response assessments
Heather Jacene,Sophie Leboullex,Shingo Baba,Daniel
Chatzifotiadis,Behnaz Goudarzi,O.Teytelbaum,K.Horton,Katarzyna
Macura,Ihab Kamel,Richard Wahl
J Nucl Med,2011;52(Supplement 1): 1773 (impact factor 7,022)
4. Treatment with 223Radium Dichloride in patients with
castrate-resistant prostate cancer, with painful
metastases and in the absence of visceral metastases
Hatzifotiadis Daniel , electronic database of University of Athens
1. The frequency of cholelithiasis in cirrhosis of the liver.
E. Christakopoulos, E. Manousakis, D. Doubles, D. Hatzifotiadis,
S. Papaspyrou.
Proceedings of the 14th Armed Forces Medical Conference (1992).
Free Gastroenterology - Endocrinology Announcements (No.
416).
2. Syndrome after cholecystectomy.
E. Christakopoulos, E. Manousakis, D. Doubles, D. Hatzifotiadis,
S. Papaspyrou.
Proceedings of the 14th Armed Forces Medical Conference (1992).
Free Gastroenterology - Endocrinology Announcements
(No. 419).
3. Evidence of faster Technetium – 99m tetrofosmin wash – out rate
from stunned myocardium after injection at test. Is it a new method for
viability detection?
T. Athanasoulis, J. Nanas, D. Hatzifotiadis, D. Kontoyiannis, P.
Kostamis.
Proceedings of the Spanish Congress of Nuclear Cardiology 1997.
San Lorentzo de el Escorial (Madrid), p. 56 (5 – 8 Feb 1997).
Reunion Internacional Cardiologica Nuclear, Madrid 1997.
4. Tc – 99m tetrofosin GATED – SPECT improves viability
assessment in post infarction patient.
J. Lekakis, R. Vezirgianni, V. Prassopoulos, G. Germanidis, J. Nanas, D.
Hatzifotiadis, N. Agrios, C Papamichael, S. Stamatelopoulos, S.
Moulopoulos, P. Kostamis.
3rd International Conference of Nuclear Cardiology, April 6 – 9, 1997,
Florence, Italy.
5. Differences between early and late Tc-99-Tetrofosmin images in
patients with recent myocardial infarction. Is it a marker of stunned
myocardium?
T. Athanasoulis, J.Nanas, D. Hatzifotiadis, D. Kontoyiannis, P.
Kostamis.
JNM, May 1997, Scientific Abstracts of the 44th Annual Meeting of
the
Society of Nuclear Medicine , San Antonio, Texas , June 1-5, 1997,
Poster . No 703,page 162.
6. Early and late Tc-99m-Tetrofosmin images in patients with recent
myocardial infarction. Comparison with thallium rest-redistributio
images.
T. Athanasoulis, J.Nanas, D. Hatzifotiadis, D. Kontoyiannis, G. E.
Alexopoulos, P. Kostamis.
Dept. of Nuclear Medicine and Therapeutic “Alexandra”
University Hospital,
European Journal of Nuclear Medicine (High – lights) 24/8, 1997 p.
950.
7. High – lights, 1997,I. Carrio, European Journal of Nuclear
Medicine: 24, 1527 –1540, Reference 54.
8. Right to left end – diastolic volume ratio calculated by Gated Spect
blood – pool imaging correlates with pulmonary artery pressure in
patients with pulmonary hypertension.
T. Athanasoulis, L. Karaloizos, K. Palaskas, D. Hatzifotiadis, Ch.
Kalliontzi, S. Gerali, S Kostamis.
45th Annual Meeting of Society of Nuclear Medicine, Toronto, Canada, 7
– 11 June 1998 (poster).
9. Comparison of Tc – 99m – V- DMSA with Tc – 99m – MDP in
diagnosis of primary breast cancer.
V. Papantoniou, A. Stypsanelli, D. Hatzifotiadis, G. Galero, A.
Keramopoulos, P. Kostamis.
6th Panhellenic Congress of Nuclear Medicine (1998), Proceedings
(Poster).
10. The role of histamine in the pulmonary manifestation in chronic
heart failure (CHIF).M. Sapranidou – Christoforaki, A. Leonti, Ch. Kostopoulos, J. Datseris, J
Nanas, K. Palaskas, D. Hatzifotiadis, Ch. Palestidis.
6th Panhellenic Congress of Nuclear Medicine (1998), Free
Announcements.
11. Radioisotope cholangiography (BRIDA) in children with
fibrocystic disease.
A. Stypsanelli, V. Papantoniou, K. Palaskas, D. Hatzifotiadis, E.
Dodunakis.
6th Panhellenic Congress of Nuclear Medicine (1998), Proceedings
(Poster).
12. Reliability of the scan with DMSA - Tc - 99m for
the assessment of gravity and the evolution of urinary tract infection in the
babyhood. Association with clinical laboratory findings.
A. Leonti, Z. Karakatsani, I. Datseris, K. Gardener, S.
Vezygianni, D. Hatzifotiadis, K. Palaskas.
6th Panhellenic Congress of Nuclear Medicine (1998), Free
Announcements.
13. Dosimetry and optimisation of the radiation protection of the
Flying Personnel of the Hellenic Air Carriers.
V. Kamenopoulou, G. Drikos, N. Pulisos, K. Stamatis, D.
Hatzifotiadis, P. Demetriou.
1st Panhellenic Congress of Air and Space Medicine, 4 - 6
October 2001, Athens.
14. Viability detection in recent myocardial infarction (MI) using Tc –
99m – Tetrofosmin (Tf) at rest,. Role of post injection imaging time
interval.
T. Athanasoulis, D. Hatzifotiadis, I. Koutsikos, S. Tsiouris, K. Mainta, M.
Stathaki, CH. Zerva.
Dept. of Nuclear Medicine, “Alexandra” University Hospital.
European Journal of Nuclear Medicine, 8/2002, pS 214, poster No 99.
15. T. Athanasoulis, CA. Zerva. Interpretation of reverse redistribution
of Tc – 99m tetrofosmin in patients with acute myocardial infarction.
(Letter to the editor)
Eur. J. Nucl. Med. Mol Imaging. 2003; 30(5):798 – 9
16. Assessment of Interobserver Reproducibility in Quantitative 18FFDG PET and CT Measurements of Tumor Response to Therapy
Heather A. Jacene, Sophie Leboulleux, Shingo Baba, Daniel
Chatzifotiadis, Behnaz Goudarzi, Oleg Teytelbaum, Karen M. Horton,
Ihab Kamel, Katarzyna J. Macura, Hua-Ling Tsai, Jeanne Kowalski
and Richard Wahl
JNM 2009 50: 11A-12A, p. 1760-1769
17. First-line chemotherapy leads to high bone turnover and reduced bone
mass in patients with non-Hodgkin’s lymphoma: Results from a
prospective study(abstract 0891)
K.Anargyrou,T.Vassilakopoulos,K.Tsionos,P.Kokkoris,G.Boutsikas,M.A
ngelopoulou,D.Christoulas,S.Masouridou,M.Dimou,A.Papatheodorou,D.
Chatzifotiadis,
P.Panagiotidis, G. Pangalis, P.Beris, E.Terpos
Hematologica-The hematology Journal
15th Congress of the European Hematology Association, Spain,
Barcelona , June 10-13,2010
18. Importance of the same or different readers pre- and posttherapy for anatomic vs. metabolic response assessments
Heather Jacene,Sophie Leboullex,Shingo Baba,Daniel
Chatzifotiadis,Behnaz Goudarzi,O.Teytelbaum,K.Horton,Katarzyna
Macura,Ihab Kamel,Richard Wahl
J Nucl Med, 2011 ; 52(Supplement 1): 1773
19. 3- Dimensional Radiogiologic Dosimetry(3D-RD) in patients
with metastatic foci of differentiated thyroid cancer to the lungs and the
brain
Poster No 24 -17th Congress of the Balkan Militery Medical Committee,
29 May-01 Jun 2012, Belgrade, Serbia
20. The usefulness of PET/CT in the investigation of patients with possible
coronary heart disease
240 Armed Forces Medical Conference (ISED), November 2010 ,
Thessaloniki, Greece
21. Applications of PET/CT in Medicine,
Cross-community Speech 02/2006,
Amphitheatre 251 ENA
22. The Usefulness of PET/CT in Pediatrics
Seminar of the Hellenic Society of Nuclear Medicine, May 2006,
Athens
23. Applications of PET/CT in Cardiology,
Cross-community Speech 10/2007,
Amphitheatre 251 ENA
24.Other oncological and non-oncological applications of SPECT/CT and the role of
25th Armed Forces Medical Conference (ISED), October 2012 ,
Thessaloniki, Greece
25. Presentation highlights of the American Society Conference
Nuclear Medicine (Miami 2012)
Seminar of the Hellenic Society of Nuclear Medicine, November 2012,
Athens
26.WDTC(Well Differentiated thyroid cancer)
The View of the Nuclear Physician
Multi-thematic Conference 251 ENA ,February 2013, Athens
27. Myocardial Neurotransmitter Imaging (MYOCARDIAL
NEUROTRANSMISSION IMAGING),
19th CARDIOLOGICAL DAY
UNIVERSITY AND MILITARY CARDOLOGICALS
CLINIC ATHENS, ATHENS, APRIL 2013
28. Ca Protector Treatment with 223Ra XOFIGO
260 Armed Forces Medical Conference (ISED), October 2016 ,
Thessaloniki, Greece
29. The usefulness of Radiotherapy with 223Ra XOFIGO in patients
with favourable prostate cancer and bone metastases
Conference of the Department of Urological Oncology of the Hellenic Society
Urology, February 2017 , Zarouchla Corinthia
30. Sparkling investigation of bone inflammation
Conference of the Department of Primary Health Care of Greece
Orthopaedics Company, June 2017 , Paros
31. Modern scintillal imaging of septic inflammations
of the back system,730 Panhellenic Orthopaedic Conference,
October 2018, Athens
32. Newer developments in Positron Imaging
(PET/CT,PET,MRI), as well as in the production of Short-lived
Radioisotopes in the same area 270 Armed Forces Medical Conference (ISED), October 2018 ,
Thessaloniki, Greece
33.The first experience in Greece of treating patients with 223RaDichloride (XOFIGO) with eunuch-resistant prostate cancer with bone
metastases and negative visceral metastases.
Complications and events 270 Medical Conference of the Armed Forces (ISED), October 2018 , Thessaloniki
34. The first experience in 251 UNA Liver Radioembolism with
microbeads with 90Y(90Y -Resinspheres) 270 Armed Forces Medical Conference (ISED) , October 2018 ,
Thessaloniki, Greece
Positron Emission Tomography and Cancer, in Alfred's book
E.Chang Oncology :An Evidence Bas
EDUCATIONAL WORK
years and in the DEPARTMENT OF APPLICABLE LEARNINGS (
DEPARTMENT OF NATIONAL METSOVIAN
POLYTECHNEY for 13 years also
SCIENTIFIC COMMITTEE MEMBER:
Scientific Committee of the 22nd Conference of the Hellenic Nuclear Society
Medicine,8-10 April 2011
I also prepare a doctoral thesis at the University of Athens on:
'RECOSISTIC THEREOF OF SECOND OSTICS
INSTRUCTIONS ON THE CARD OF THE MASTE WITH CONNECTION
CHLORIUM STRONIUM -89(89SrCl2) AND SAMARIUM 153 ETHYLENODIAMIN-TETRAMETHYLEN-PHOSPHONIC ACID(153Sm-EDTMP);
RESEARCH RADIOISOTOPIC STUDY IN VIVO" IN THE 1st LABORATORY
ATTINOLOGY OF THE ECSC
I was also a speaker at nuclear medicine conferences, the Greek
Pancreatic Society, at the Multi-Thematic Conferences of 251 ENA, in workshops
other specialties in 251 UNA, in workshops of the School of Nuclear and
Biological Warfare of the GEA, in continuing education courses of the
Hellenic Society of Nuclear Medicine, I participated in written announcements at the Conferences of VESI (Balkan Congress of Military Medicine) in 2010 and 2012. I also have teaching work in post-training seminars of the Hellenic Society of Nuclear Medicine and Molecular Biology, of which I was a representative in Europe from 2010 to 2012 (UEMS).
Speaker at the 3rd BbX Defence Conference (22-09-03 to 23-09-03), with two speeches with
topics: Natural Principles of Electromagnetic Radiation and Dosimetry and
Radio detection.
I hold PROFICIENCY in English (updated in
11/2014) , and the A2 in Mandarin-Chinese, while I speak a little
French (level A2).
SERVICE SCHOOLS:
Defence (SPIVICHA) : From 14-04-03 to 22-04-03 .
2. 12th Olympic School of Defence BCX :
From 07-04-03 to 11-04-03 (at the School of Application of 401 GSNA).
3.School of Aviation Medicine (Series 22a): Graduation 15-05-92
4. School of Aviation Warfare (SPA/K now ADISPO): Graduation
17-07-02
I have attended the Panhellenic Conferences of Nuclear Medicine in
2000, 2002,2004,2010, and 2011, the European Conferences of the
2003,2006,2010,2011,2012,2017,2018 ,US 2005,2011,2012,
Australian 2014 , 2016, 2018, World 2014 and
2018 , the World for Ga-68 to 2015 and post-educational
seminars on the continuing education of JOHNS HOPKINS in
2004,2006,2009,2012 , 2015 and many ongoing seminars
education of the Hellenic Society of Nuclear Medicine (with many
CME hours).
I am also a member since 08/2014 of the World Union
Radiotherapeutics (WARMTH) to date and I participate in
various events at the World Atomic Energy Commission
in Vienna